Literature DB >> 9861923

Ocular toxicity from ethambutol: a review of four cases and recommended precautions.

P Sivakumaran1, A C Harrison, J Marschner, P Martin.   

Abstract

AIMS: To document the clinical and demographic features of cases of ethambutol ocular toxicity, to review the literature on this subject and to critically review current guidelines for ethambutol administration.
METHODS: Cases of ocular toxicity from ethambutol were sought retrospectively at Green Lane and Wellington Hospitals between 1992 and 1995. The records of cases identified were examined.
RESULTS: Four subjects with tuberculosis developed ocular toxicity 2 1/2, 7 1/2, 8 and 12 months after starting ethambutol. Normal visual acuity returned in three cases; one patient has severe, permanent visual impairment. Language difficulties were present in three subjects.
CONCLUSIONS: Impaired communication was potentially very important in this series. Special care is needed in educating patients about ethambutol. We propose additional recommendations: 1. the usual daily dose of ethambutol should be 15 mg/kg/day, not 25 mg/kg/day; using 25 mg/kg/day (or lesser doses in the presence of renal impairment) should prompt regular formal ophthalmological evaluation (e.g. monthly) in cases with comprehension or communication difficulties; 3. both ethambutol and isoniazid should be stopped immediately if severe optic neuritis occurs. Isoniazid should be stopped if less severe optic neuritis does not improve within six weeks after stopping ethambutol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861923

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  16 in total

1.  Spectrum and Clinical Course of Visual Field Abnormalities in Ethambutol Toxicity.

Authors:  Thomas Mendel; David Fleischman; R Rand Allingham; Henry Tseng; David A Chesnutt
Journal:  Neuroophthalmology       Date:  2016-04-29

2.  Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.

Authors:  Samantha J Chai; Rod Foroozan
Journal:  Br J Ophthalmol       Date:  2007-01-10       Impact factor: 4.638

3.  Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.

Authors:  Christopher I Zoumalan; Madhu Agarwal; Alfredo A Sadun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-23       Impact factor: 3.117

Review 4.  Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians.

Authors:  Matt Mason; Eric Gregory; Keith Foster; Megan Klatt; Sara Zoubek; Albert J Eid
Journal:  Open Forum Infect Dis       Date:  2022-06-15       Impact factor: 4.423

5.  Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.

Authors:  Xiaolei Pan; Li Wang; Dirk Gründemann; Douglas H Sweet
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

6.  PKCδ-dependent signaling mediates ethambutol-induced toxic effects on human retinal pigment cells.

Authors:  Rong Kung Tsai; Ming Shan He; Zih-Yao Chen; Wen Chen Wu; Wen Sheng Wu
Journal:  Mol Vis       Date:  2011-06-09       Impact factor: 2.367

7.  Ethambutol induces impaired autophagic flux and apoptosis in the rat retina.

Authors:  Shun-Ping Huang; Jia-Ying Chien; Rong-Kung Tsai
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

8.  Mycobacterium tuberculosis and pemphigus vulgaris.

Authors:  Katarzyna Osipowicz; Cezary Kowalewski; Katarzyna Woźniak
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

9.  The use of optical coherence tomography for the detection of ocular toxicity by ethambutol.

Authors:  Brunella Maria Pavan Taffner; Felipe Berno Mattos; Mariana Cartaxo da Cunha; Fábio Petersen Saraiva
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

10.  Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy.

Authors:  Ki Won Jin; Joo Yeon Lee; Soolienah Rhiu; Dong Gyu Choi
Journal:  PLoS One       Date:  2019-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.